Los Angeles Times | May 24, 2022
“This is a very good vaccine, but the FDA has slow-walked it every step of the way,” said Lawrence Gostin, an expert in public health law expert at Georgetown University.
Los Angeles Times | May 24, 2022
“This is a very good vaccine, but the FDA has slow-walked it every step of the way,” said Lawrence Gostin, an expert in public health law expert at Georgetown University.
In The News
October 30, 2024
In The News
October 22, 2024
In The News
October 21, 2024